The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 04, 2023

Filed:

Aug. 18, 2022
Applicant:

Aseko, Inc., Greenville, SC (US);

Inventors:

Robert C. Booth, Greer, SC (US);

Harry Hebblewhite, Atlanta, GA (US);

Assignee:

Aseko, Inc., Greenville, SC (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G16H 40/67 (2018.01); A61M 5/172 (2006.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61M 5/14 (2006.01); G16H 20/17 (2018.01); G16H 80/00 (2018.01); G16H 10/40 (2018.01); G16H 20/60 (2018.01); A61M 5/142 (2006.01);
U.S. Cl.
CPC ...
G16H 40/67 (2018.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61M 5/14 (2013.01); A61M 5/1723 (2013.01); G16H 10/40 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 80/00 (2018.01); A61B 5/4848 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/14296 (2013.01); A61M 2005/1726 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/35 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/507 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2230/201 (2013.01);
Abstract

A method of administering insulin includes receiving glucose measurements of a patient at a data processing device from a continuous glucose monitoring system. The glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.


Find Patent Forward Citations

Loading…